期刊文献+

犬冠状动脉内植入过大支架──一种新的再狭窄模型 被引量:5

The implantation of oversized stent in canine coronary artery: A new animal model of restenosis
原文传递
导出
摘要 为建立一种新的再狭窄模型,初步探讨再狭窄的形成机理。在16只犬冠状动脉内植入过大的钽丝支架,28d后用常规HE、免疫组化和原位杂交方法作组织学分析。结果:新生内膜厚度与血管壁损伤程度呈正相关,新生内膜中含有大量血管平滑肌细胞及胶原纤维,血小板源生长因子主要由内皮细胞分泌但其受体主要分布于新生血管平滑肌细胞。提示:犬冠状动脉内植入过大钽丝支架可作为一种新的动物模型,并为临床研究提供依据。 To develop a new animal model of restenosis oversized tantalum coils were deli vered into coronary arteries of 16 dogs. At 28 days after implantation, the target vessels were har vested and studied with HE staining, immunohistochemistry and in situ hybridization. The neointi mal thickness was related to the vascular injury score. A great deal of smooth muscle cells and col lagen were found in the neointiml. The platelet-derived growth factor-B was secreted from the en dothelial cells primarily but its receptor was located in the proliferative smooth muscle cells. It suggests that implantation of oversized stent in canine coronary artery can create a new animal model of restenosis. The mechanism of restenosis and the relation of oncogenes to restenosis were discussed.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 1997年第4期225-228,共4页 Journal of Clinical Cardiology
关键词 动物模型 冠状动脉狭窄 支架 冠状动脉成形术 Restenosis Animal model In situ hybridization Oncogene
  • 相关文献

同被引文献20

  • 1向定成 黄大显 等.去纤酶对实验性犬冠状动脉成形术后内膜增生的抑制作用[J].中国循环杂志,1996,11(5):278-278.
  • 2向定成 黄大显 等.去纤酶对实验性犬冠状动脉形成术后内膜增生的抑制作用[J].中国循环杂志,1996,11(5):278-278.
  • 3向定成 黄大显 等.去纤酶对血管损伤后内膜V-sis基因转录和PDGF-BB表达的影响[J].解放军医学杂志,1998,23(1):8-8.
  • 4[1]Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanism. J Am Cardiol Coll, 1992,20:1284-1293.
  • 5[4]O′Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primary and restenosis coronary atherectomy tissues: implications for antiproliferative therapy. Circ Res, 1993,73:223-229.
  • 6[5]Pickering JG, Weir L, Jekanowski J, et al. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest, 1993,91:1469-1475.
  • 7[6]Yla-Herttuala S, Sumuvuori H, Karkola K, et al. Glycosaminoglycans in normal and atherosclerotic human coronary arteries. Lab Invest, 1986,54:402-407.
  • 8Hehrlein C, Kubler W. Advantages and limitations of radioactive stents. Semin Interv Cardiol, 1997, 2 (2) : 109-113.
  • 9Nath R, Amols H, Coffey C, Duggan D, Jani S, Li Z, et al. Intravascular brachytherapy physics; report of the AAPM Radiation Therapy Committee Task Group No. 60, American Association of Physicists in Medicine. Med Phys,1999, 26 (2): 119-152.
  • 10Crocker I. Radiation therapy to prevent artery restenosis. Semin Radat Oncol,1999, 9 (2): 134-143.

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部